Filing Details
- Accession Number:
- 0000899243-17-025506
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-11-07 16:05:30
- Reporting Period:
- 2017-11-06
- Accepted Time:
- 2017-11-07 16:05:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1701108 | Spero Therapeutics Inc. | SPRO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1721173 | Cristina Larkin | C/O Spero Therapeutics, Inc. 675 Massachusetts Avenue, 14Th Floor Cambridge MA 02139 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-11-06 | 1,500 | $14.00 | 1,500 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Reflects shares that were purchased through a directed share program in connection with the Issuer's initial public offering.
Billionaire Hedge Funds
